$3.32
0.010000.30%
At close: -
$3.32
0.000.00%
After Hours: 7:15 PM EDT
Comments
Loading...
Qualigen Therapeutics Analyst Ratings and Price Targets | NASDAQ:QLGN | Benzinga
Qualigen Therapeutics Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Qualigen Therapeutics Corp from these most-recent analyst ratings.
Analyst Ratings for Qualigen Therapeutics
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Qualigen Therapeutics (QLGN) stock?
There is no price target for Qualigen Therapeutics
What is the most recent analyst rating for Qualigen Therapeutics (QLGN)?
There is no analyst for Qualigen Therapeutics
When was the last upgrade for Qualigen Therapeutics (QLGN)?
There is no last upgrade for Qualigen Therapeutics
When was the last downgrade for Qualigen Therapeutics (QLGN)?
There is no last downgrade for Qualigen Therapeutics.
When is the next analyst rating going to be posted or updated for Qualigen Therapeutics (QLGN)?
There is no next analyst rating for Qualigen Therapeutics.
Is the Analyst Rating Qualigen Therapeutics (QLGN) correct?
There is no next analyst rating for Qualigen Therapeutics.
Browse analyst ratings and price targets on all stocks.